Impact of RECK gene polymorphisms and environmental factors on oral cancer susceptibility and clinicopathologic characteristics in Taiwan

Carcinogenesis

Volumn 32, Issue 7, 2011, Pages 1063-1068

  Chung, Tsung Te ^a,b   Pan, Min Shing ^b   Kuo, Chien Long ^b   Wong, Ruey Hong ^a   Lin, Chiao Wen ^a   Chen, Mu Kuan ^a,c   Yang, Shun Fa ^a,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; PROTEIN DERIVATIVE; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BETEL NUT; CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE FREE INTERVAL; DOWN REGULATION; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HISTOPATHOLOGY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTICATION; MOUTH CANCER; PRIORITY JOURNAL; REVERTANT; TAIWAN; WILD TYPE;

EID: 79960067138     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr083     Document Type: Article

References (38)

1. Noda,M. et al. (1989) Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc. Natl Acad. Sci. USA, 86, 162-166.
2. Noda,M. et al. (2003) RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev., 22, 167-175.
3. Takahashi,C. et al. (1998) Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc. Natl Acad. Sci. USA, 95, 13221-13226.
4. Oh,J. et al. (2001) The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell, 107, 789-800.
5. Masui,T. et al. (2003) RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clin. Cancer Res., 9, 1779-1784.
6. Span,P.N. et al. (2003) Matrix metalloproteinase inhibitor reversioninducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma. Cancer, 97, 2710-2715.
7. Takenaka,K. et al. (2004) Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer. Eur. J. Cancer, 40, 1617-1623.
8. Takeuchi,T. et al. (2004) The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clin. Cancer Res., 10, 5572-5579.
9. Li,Y. et al. (2005) Expression of RECK gene and MMP-9 in hilar cholangiocarcinoma and its clinical significance. J. Huazhong Univ. Sci. Technolog. Med. Sci., 25, 552-554.
10. Song,S.Y. et al. (2006) Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer. Eur. J. Cancer, 42, 101-108.
11. Rabien,A. et al. (2007) Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy. Eur. Urol., 51, 1259-1266.
12. Takemoto,N. et al. (2007) Low expression of reversion-inducing cysteinerich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung. Lung Cancer, 58, 376-383.
13. Long,N.K. et al. (2008) Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas. Oral Oncol., 44, 1052-1058.
14. Qi,M. et al. (2010) [Clinicopathological significance of expressions of RECK and MMP-2 in esophageal squamous carcinoma]. Zhonghua Zhong Liu Za Zhi, 32, 283-285.
15. Xu,J. et al. (2010) Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma. J. Orthop. Res., 28, 1621-1625.
16. Zavras,A.I. et al. (2011) Metallothionein-1 genotypes in the risk of oral squamous cell carcinoma. Ann. Surg. Oncol., 18, 1478-1483.
17. Ko,Y.C. et al. (1995) Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J. Oral Pathol. Med., 24, 450-453.
18. Lu,C.T. et al. (1996) A case-control study of oral cancer in Changhua County, Taiwan. J. Oral Pathol. Med., 25, 245-248.
19. International HapMap Consortium. (2003) The International HapMap Project. Nature, 426, 789-796.
20. Anantharaman,D. et al. (2007) Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis, 28, 1455-1462.
21. Tu,H.F. et al. (2007) Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. J. Oral Pathol. Med., 36, 409-414.
22. Bau,D.T. et al. (2010) Association between DNA repair gene ATM polymorphisms and oral cancer susceptibility. Laryngoscope, 120, 2417-2422.
23. Chen,M.K. et al. (2010) Glutathione S-transferase P1 and alpha gene variants; role in susceptibility and tumor size development of oral cancer. Head Neck, 32, 1079-1087.
24. Weng,C.J. et al. (2010) Impact of uPA system gene polymorphisms on the susceptibility of environmental factors to carcinogenesis and the development of clinicopathology of oral cancer. Ann. Surg. Oncol., 18, 805-812.
25. Chung,Y.T. et al. (2009) Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese. Carcinogenesis, 30, 286-294.
26. Eisenberg,I. et al. (2002) Establishment of the genomic structure and identification of thirteen single-nucleotide polymorphisms in the human RECK gene. Cytogenet. Genome Res., 97, 58-61.
27. Yen,T.T. et al. (2008) The association of smoking, alcoholic consumption, betel quid chewing and oral cavity cancer: a cohort study. Eur. Arch. Otorhinolaryngol., 265, 1403-1407.
28. Yang,Y.H. et al. (2005) Incidence rates of oral cancer and oral precancerous lesions in a 6-year follow-up study of a Taiwanese aboriginal community. J. Oral Pathol. Med., 34, 596-601.
29. Tang,D.W. et al. (2004) Hydroxychavicol modulates benzo[a]pyreneinduced genotoxicity through induction of dihydrodiol dehydrogenase. Toxicol. Lett., 152, 235-243.
30. Wu,H.J. et al. (2005) Effects of pH on nicotine-induced DNA damage and oxidative stress. J. Toxicol. Environ. Health A, 68, 1511-1523.
31. Kuo,M.Y. et al. (1995) Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinoma in Taiwan. J. Oral Pathol. Med., 24, 255-260.
32. Kuo,M.Y. et al. (1994) Mutations of Ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan. J. Oral Pathol. Med., 23, 70-74.
33. Sasahara,R.M. et al. (2002) Transcriptional control of the RECK metastasis/angiogenesis suppressor gene. Cancer Detect. Prev., 26, 435-443.
34. Liu,S.Y. et al. (2005) Increased expression of matrix metalloproteinase-2 in oral cells after short-term stimulation and long-term usage of areca quid. J. Formos. Med. Assoc., 104, 390-397.
35. Liu,S.Y. et al. (2005) Areca quid chewing enhances the expression of salivary matrix metalloproteinase-9. J. Formos. Med. Assoc., 104, 113-119.
36. Ku,K.T. et al. (2005) Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancer. Oral Oncol., 41, 497-502.
37. Rundhaug,J.E. (2003) Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9: 00-00, 2003. Clin. Cancer Res., 9, 551-554.
38. Chang,H.C. et al. (2007) Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer. Cancer Sci., 98, 169-173.